Background. Lichen sclerosus (LS) is a chronic disease of the skin, for which the pathogenesis is not known. It can lead to various changes of the skin and the genital area, potentially leading to both functional as well as cosmetic problems for the patient, thus disrupting the quality of life. In this study; the purpose was to review the clinical characteristics and the treatments of the 15 pediatric patients under the age of 18 followed up in our out-patient clinic with a diagnosis of LS and to compare the findings with literature data. Methods. Between 2011 and 2017, the files of 15 patients diagnosed clinically and/or histologically with LS in our clinic were retrospectively examined. The demographic characteristics, clinic and laboratory findings, treatment options of the patients are reported. Results. Of the patients included in the study 14 were girls and one was a boy. The average age was 11.6 years (5-17 years), the average age for the initial disease was 7.8 years (2-13 years). The average duration of the disease at the diagnosis was 3.9 years. The most common form was genital vulvar type (8/14 girls) without anal and cutaneous involvement, and each of them suffered from itching. One of the cases had genital LS as well as extragenital morphea lesions. Two of the 15 patients were ANA positive. The other antibodies were negative. In two cases with extragenital involvement, lesions were widespread and they were in blachkoid form. Conclusion. LS is a chronic disease that progresses with recurrences and regressions. In our study, the most common LS type was genital type (60%). There was extragenital involvement in 6 patients (40%). Extragenital involvement was the most common on the trunk. Diagnosis, treatment and follow-up during childhood is highly important to prevent any possible future anatomical or psychological damage and genital malignancies.
___
1. Rőcken M, Ghoreschi K. Morfea ve liken skleroz. Bolognia JL, Jorizzo JL, Rapini RP (eds). Dermatoloji (2. Basım) Cilt 2. İstanbul: Nobel Kitapevi, 2012: 1462-1476.
2. Hallopeau H. Lichen plan sclereux. Ann Dermatol Syph 1889; 10: 447-449.
3. Monsálvez V, Rivera R, Vanaclocha F. Lichen sclerosus. Actas Dermosifiliogr 2010; 101: 31-38.
4. Tong LX, Sun GS, Teng JM. Pediatric lichen sclerosus: a review of the epidemiology and treatment options. Pediatr Dermatol 2015; 32: 593-599.
5. Neill SM. Vulvovajinitis and lichen sclerosus In: Harper J, Orange A, Prose N (eds). Texbook of Pediatric Dermatology. (2nd ed) Vol 2. Massachusetts: Blackwell Science, 2006: 1822-1826.
6. Morrel B, van Eersel R, Burger CW, et al. The longterm clinical consequences of juvenile vulvar lichen sclerosus: a systematic review. J Am Acad Dermatol 2020; 82: 469-477.
7. Fistarol SK, Itin PH. Diagnosis and treatment of lichen sclerosus: an update. Am J Clin Dermatol 2013; 14: 27-47.
8. Nair PA. Vulvar Lichen sclerosus et atrophicus. J Midlife Health 2017; 8: 55-62.
9. Ergin S. Liken sklerozus. Türk Dermatoloji Dergisi 2012; 6: 27-34.
10. Bercaw-Pratt JL, Boardman LA, Simms-Cendan JS; North American Society for Pediatric and Adolescent Gynecology. Clinical recommendation: pediatric lichen sclerosus. J Pediatr Adolesc Gynecol 2014; 27: 111-116.
11. Paller AS, Mancini AJ. Collogen vasculer disorders. In: Hurwitz Clinical Pediatric Dermatology: A Textbook of Skin Disorders of Childhood and Adolescence. (3rd ed). Chine: Elsevier Inc, Saunders, 2006: 599-600.
12. Meyric Thomas RH, Ridley CM, Mc Gibbon DH, Black MM. Lichen sclerosus et atrophicus and autoimmunity: a study of 350 women. Br J Dermatol 1988; 118: 41-46.
13. Neill SM, Lewis FM, Tatnall FM, Cox NH; British Association of Dermatologists. British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010. Br J Dermatol 2010; 163: 672-682.
14. Dinh H, Purcell SM, Chung C, Zaenglein AL. Pediatric lichen sclerosus: a review of the literature and management recommendations. J Clin Aesthet Dermatol 2016; 9: 49-54
15. Kirtschig G. Lichen sclerosus-presentation, diagnosis and management. Dtsch Arztebl Int 2016; 113: 337-343.
16. Smith SD, Fischer G. Childhood onset vulvar lichen sclerosus does not resolve at puberty: a prospective case series. Pediatr Dermatol 2009; 26: 725-729.
17. Powell J, Wojnarowska F. Childhood vulvar lichen sclerosus: an increasingly common problem. J Am Acad Dermatol 2001; 44: 803-806.
18. Chi CC, Kirtschig G, Baldo M, et al. Systematic review and meta-analysis of randomized controlled trials on topical interventions for genital lichen sclerosus. J Am Acad Dermatol 2012; 67: 305-312.
19. Gutte R, Khopkar U. Extragenital unilateral lichen sclerosus et atrophicus in a child: a case report. Egyptian Dermatol J 2011; 7: 10.
20. Viana Fde O, Cavaleiro LH, Unger DA, Miranda MF, Brito AC. Acral lichen sclerosus et atrophicuscase report. An Bras Dermatol 2011; 86(4 Suppl 1): S82-S84.
21. Kim CR, Jung KD, Kim H, et al. Linear lichen sclerosus along the Blaschko’s line of the face. Ann Dermatol 2011; 23: 222-224.
22. Kreuter A, Wischnewski J, Terras S, Altmeyer P, Stücker M, Gambichler T. Coexistence of lichen sclerosus and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center. J Am Acad Dermatol 2012; 67: 1157-1162.
23. Bjekić M, Šipetić S, Marinković J. Risk factors for genital lichen sclerosus in men. Br J Dermatol 2011; 164: 325-329.
24. Carlson JA, Lamb P, Malfetano J, Ambros RA, Mihm MC Jr. Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesion, and etiology of 141 cases. Mod Pathol 1998; 11: 844-854.
25. Tomo S, Santos IS, de Queiroz SA, Bernabé DG, Simonato LE, Miyahara GI. Uncommon oral manifestation of lichen sclerosus: critical analysis of cases reported from 1957 to 2016. Med Oral Patol Oral Cir Bucal 2017; 22: e410-e416.
26. An İ, Uçmak D, İbiloğlu İ. Çocukluk çağında görülen ekstragenital yerleşimli liken skleroz: dört olgu sunumu. Turkiye Klinikleri J Dermatol 2017; 27: 109-112.
27. Tepe B, Erdoğdu Hİ, Aydın Türk B. İki çocukta extragenital lokalizasyonlu liken skleroz. Turkiye Klinikleri J Dermatol 2016; 26: 117-120.
28. Kandi CB, Saral Y, Ataseven A, Özercan İH, Çiçek D. Çocukluk çağında görülen ekstragenital yerleşimli liken sklerozis olgusu: Fırat Tıp Dergisi 2004; 9: 62- 64.
29. Celis S, Reed F, Murphy F, et al. Balanitis xerotica obliterans in children and adolescents: a literature review andclinical series. J Pediatr Urol 2014; 10: 34- 39.
30. Jensen LS, Bygum A. Childhood lichen sclerosus is a rare but important diagnosis. Dan Med J 2012; 59: A4424.
31. Nerantzoulis I, Grigoriadis T, Michala L. Genital lichen sclerosus in childhood and adolescence-a retrospective case series of 15 patients: early diagnosis is crucial to avoid long-term sequelae. Eur J Pediatr 2017; 176: 1429-1432.
32. Sherman V, McPherson T, Baldo M, Salim A, Gao XH, Wojnarowska F. The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study. J Eur Acad Dermatol Venereol 2010; 24: 1031-1034.
33. Helm KF, Gibson LE, Muller SA. Lichen sclerosus et atrophicus in children and young adults. Pediatr Dermatol 1991; 8: 97-101.
34. Eisendle K, Grabner T, Kutzner H, Zelger B. Possible role of Borrelia burgdorferi sensu lato infection in lichen sclerosus. Arch Dermatol 2008; 144: 591-598.
35. Aberer E, Stanek G. Histological evidence for spirochetal origin of morphea and lichen sclerosus et atrophicans. Am J Dermatopathol 1987; 9: 374-379.
36. Edmonds E, Mavin S, Francis N, Ho-Yen D, Bunker C. Borrelia burgdorferi is not associated with genital lichen sclerosus in men. Br J Dermatol 2009; 160: 459- 460.
37. Aidé S, Lattario FR, Almeida G, do Val IC, da Costa Carvalho M. Epstein-Barr virus and human papillomavirus infection in vulvar lichen sclerosus. J Low Genit Tract Dis 2010; 14: 319-322.
38. Ozkan S, Atabey N, Fetil E, Erkizan V, Günes AT. Evidence for Borrelia burgdorferi in morphea and lichen sclerosus. Int J Dermatol 2000; 39: 278-283.
39. Cooper SM, Ali I, Baldo M, Wojnarowska F. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol 2008; 144: 1432- 1435.
40. Kreuter A, Kryvosheyeva Y, Terras S, et al. Association of autoimmune diseases with l i c h e n sclerosus in 532 male and female patients. Acta Derm Venereol 2013; 93: 238-241.
41. Oyama N, Chan I, Neill SM, et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 2003; 362: 118-123.
42. Powell J, Wojnarowska F. Childhood vulvar lichen sclerosus. The course after puberty. J Reprod Med 2002; 47: 706-709.
43. Depasquale I, Park AJ, Bracka A. The treatment of balanitis xerotica obliterans. BJU Int 2000; 86: 459- 465.
44. Murphy R. Lichen sclerosus. Dermatol Clin 2010; 28: 707-715.
45. Ceylan N, Gürel MS, Kiremitçi Ü, Demirkesen C. Jeneralize morfea-liken skleroatrofik birlikteliği. Türk Patoloji Dergisi 2008; 24: 179-182.
46. Bunker CB. Comments on the British Association of Dermatologists guidelines for the management of lichen sclerosus. Br J Dermatol 2011; 164: 894 -895.
47. Kirtschig G, Becker K, Günthert A, et al. Evidencebased (S3) guideline on(anogenital) lichen sclerosus. J Eur Acad Dermatol Venereol 2015; 29: e1-e43.
48. Kreuter A, Gambichler T, Breuckmann F, et al. Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma. Arch Dermatol 2005; 141: 847-852.
49. Parlak N, Akay BN, Şanlı HE, Akyol A. Morfealı hastalarda klinik özellikler, laboratuvar bulguları, seçilen tedavi yöntemi ve takip sonuçları. TurkdermDeri Hastalıkları ve Frengi Arşivi Dergisi 2013; 47: 209-213.
50. El-Sakka AI, Bakircioglu ME, Bhatnagar RS, Yen TS, Dahiya R, Lue TF. The effects of colchicine on a Peyronie’s-like condition in an animal model. J Urol 1999; 161: 1980-1983.
51. Anderson K, Ascanio NM, Kinney MA, Krowchuk DP, Jorizzo JL. A retrospective analysis of pediatric patients with lichen sclerosus treated with a standardprotocol of class I topical corticosteroid and topical calcineurin inhibitor. Dermatolog Treat 2016; 27: 64-66.
52. Casey GA, Cooper SM, Powell JJ. Treatment of vulvar lichen sclerosus with topical corticosteroids in children: a study of 72 children. Clin Exp Dermatol 2015; 40: 289-292.
53. Cooper SM, Gao XH, Powell JJ, Wojnarowska F. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol 2004; 140: 702-706.
54. Focseneanu MA, Gupta M, Squires KC, Bayliss SJ, Berk D, Merritt DF. The course of lichen sclerosus diagnosed prior to puberty. J Pediatr Adoles Gynecol 2013; 26: 153-155